USING VIRAL NANOPARTICLES TO TARGET CANCER
USING VIRAL NANOPARTICLES TO TARGET CANCER
批准号:
7558948
负责人:
MARIANNE MANCHESTER
金额:
$74.79万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-03-01 至 2009-10-31
关键词:
Animal ModelBindingBiochemicalBiologicalBiological AvailabilityBiologyBiopsyCellsChemicalsChemistryChimera organismContractsCowpea Mosaic VirusesDevelopmentEarly DiagnosisGenesGenomeGoalsImageIn VitroInsect VirusesKnowledgeLabelLaboratoriesLeadMalignant NeoplasmsMolecular BiologyNanotechnologyNational Cancer InstituteOperative Surgical ProceduresPeptidesPlant VirusesProcessPropertyProteinsQuality of lifeRelative (related person)Research PersonnelSolutionsStructureSurfaceSystemTechniquesTechnologyTestingTherapeutic AgentsVirusWorkbasecancer therapycellular targetingchemical geneticscostdesignexperienceimprovedin vivomultidisciplinaryneoplastic cellnovelparticleprogramsresearch studysensortumortumor progressiontumorigenesisuptakeviral nanoparticle
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Nanotechnology holds great promise for the early detection and treatment of cancer. The ability to both detect and follow the initiation and progression of cancer without biopsy, surgery, or other invasive techniques should lead to lower costs and higher quality of life. The goal of this proposal is to develop viral nanoparticles (VNPs) as platforms for combination tumor targeting and imaging agents in vivo. Our multidisciplinary team combines molecular biology, structure, chemistry and in vivo biology to attack this problem. In this proposal we will study two well-characterized viruses: a plant virus, cowpea mosaic virus (CPMV); and an insect virus, flockhouse virus (FHV). The accumulated knowledge of the structure, function, assembly, genome packaging, chemical attachment, and in vivo bioavailability of FHV and CPMV, developed in the co-investigators' laboratories, makes these viruses ideal candidates for such platform development. We will test the ability of tumor-specific VNPs to attack tumor cells in vitro and in vivo, and study mechanisms of uptake of VNPs into cells. We will also package anti-tumor compounds and inhibitory genes inside the particles to facilitate tumor destruction. Finally we will test the ability of our VNPs to detect and destroy tumors in vivo. These studies will make a significant contribution to the development of improved tumor targeting and imaging nanotechnologies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multivalent VAccines for Biodefense
-
批准号:7849969
-
项目类别:
-
资助金额:$26.11万
-
财政年份:2009
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Multivalent VAccines for Biodefense
-
批准号:7739980
-
项目类别:
-
资助金额:$26.11万
-
财政年份:2009
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Receptor Decoy Inhibitor of Anthrax Toxin
-
批准号:7363773
-
项目类别:
-
资助金额:$49.65万
-
财政年份:2008
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Receptor Decoy Inhibitor of Anthrax Toxin
-
批准号:8206699
-
项目类别:
-
资助金额:$46.42万
-
财政年份:2008
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Receptor Decoy Inhibitor of Anthrax Toxin
-
批准号:7545937
-
项目类别:
-
资助金额:$47.37万
-
财政年份:2008
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Receptor Decoy Inhibitor of Anthrax Toxin
-
批准号:7751278
-
项目类别:
-
资助金额:$46.89万
-
财政年份:2008
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Receptor Decoy Inhibitor of Anthrax Toxin
-
批准号:8018959
-
项目类别:
-
资助金额:$46.42万
-
财政年份:2008
-
负责人:MARIANNE MANCHESTER
-
依托单位:
COLUMN FRACTION SCREENING OF CPMV PARTICLES
-
批准号:7602763
-
项目类别:
-
资助金额:$3.58万
-
财政年份:2007
-
负责人:MARIANNE MANCHESTER
-
依托单位:
USING VIRAL NANOPARTICLES TO TARGET CANCER
-
批准号:7003678
-
项目类别:
-
资助金额:$72.69万
-
财政年份:2005
-
负责人:MARIANNE MANCHESTER
-
依托单位:
USING VIRAL NANOPARTICLES TO TARGET CANCER
-
批准号:7360311
-
项目类别:
-
资助金额:$74.67万
-
财政年份:2005
-
负责人:MARIANNE MANCHESTER
-
依托单位:
USING VIRAL NANOPARTICLES TO TARGET CANCER
-
批准号:8053071
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2005
-
负责人:MARIANNE MANCHESTER
-
依托单位:
USING VIRAL NANOPARTICLES TO TARGET CANCER
-
批准号:6860578
-
项目类别:
-
资助金额:$72.28万
-
财政年份:2005
-
负责人:MARIANNE MANCHESTER
-
依托单位:
USING VIRAL NANOPARTICLES TO TARGET CANCER
-
批准号:7193491
-
项目类别:
-
资助金额:$72.65万
-
财政年份:2005
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Multivalent display of anthrax toxin inhibitors
-
批准号:6674214
-
项目类别:
-
资助金额:$103.36万
-
财政年份:2003
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Multivalent display of anthrax toxin inhibitors
-
批准号:7188076
-
项目类别:
-
资助金额:$206.49万
-
财政年份:2003
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Multivalent display of anthrax toxin inhibitors
-
批准号:6804942
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2003
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Multivalent display of anthrax toxin inhibitors
-
批准号:6852693
-
项目类别:
-
资助金额:$206.03万
-
财政年份:2003
-
负责人:MARIANNE MANCHESTER
-
依托单位:
Multivalent display of anthrax toxin inhibitors
-
批准号:7019138
-
项目类别:
-
资助金额:$206.87万
-
财政年份:2003
-
负责人:MARIANNE MANCHESTER
-
依托单位:
ROLE OF CD46 IN MEASLES ENTRY AND IMMUNOSUPPRESSION
-
批准号:6374360
-
项目类别:
-
资助金额:$31.06万
-
财政年份:2000
-
负责人:MARIANNE MANCHESTER
-
依托单位:
ROLE OF CD46 IN MEASLES ENTRY AND IMMUNOSUPPRESSION
-
批准号:6752053
-
项目类别:
-
资助金额:$31.06万
-
财政年份:2000
-
负责人:MARIANNE MANCHESTER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: